Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial

This data is for "Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial".本数据集关联一项题为"腹腔镜D2胃切除术后进展期胃癌患者辅助化疗方案对比：替吉奥（s-1）联合奥沙利铂（SOX）与卡培他滨联合奥沙利铂（CAPOX）的随机对照临床试验"的研究。